GDC-0152, soluble in DMSO, water and ethanol, is a molecule designed to neutralize the function of IAPs, thereby promoting apoptosis, especially in cancer cells. It targets cIAP1-BIR2, cIAP1-BIR3, cIAP2-BIR2, cIAP2-BIR3, MLXBIR3SG, XIAP-BIR2, and XIAP-BIR3.
GDC-0152 can be studied for its role in binding to IAPs and promoting apoptotic pathways in cancer treatment.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.